BREAKING
OpenAI Researcher Eyes $2B Drug Startup
0
M
Raise (USD)
0
B
Valuation (USD)
The Focus: Drug Repurposing
1
Existing drugs
↓
2
AI finds new uses
↓
3
Faster approval path
From Frontier Labs to Biology
Miles Wang
OpenAI RL team
●
Left Harvard in March 2024
●
Co-authored AI science work
●
Several colleagues may join
Round Lead
Lightspeed
●
Talks still in progress
●
Terms may change
●
Wang disputes some figures
AI Drug Discovery Cash Surge
Chai Discovery
3.8
Isomorphic Labs
2.1
Wang venture
2
A Test for AI in Medicine
AI NEWS BLITZ
OpenAI researcher Miles Wang is in advanced talks to launch an AI drug-discovery startup.